This journal is © The Royal Society of Chemistry 2013 J. Name., 2013, 00, 1-3 | 1 Hematotoxicity of magnetite nanoparticles coated with dimercaptosuccinic acid (DMSA) and polyethylene glycol (PEG) has been evaluated by determining their safety in vitro and in vivo in a rat model up to 30 days after administration of a single dose. The in vitro analysis consists on global plasma coagulation (PT, aPTT, Fibrinogen) and platelet aggregation tests while the hematotoxicity studies in vivo include a complete blood count and the possible genotoxic effects analysis in the bone marrow hematopoietic function. Prolonged aPTT values indicate higher anticoagulant effect for NP-DMSA compared with PEG-coated nanoparticles as a consequence of the higher surface charge of the former. The in vivo tests showed that these bioferrofluids do not cause genotoxic effects, affect erythropoiesis or increase the number of immature erythrocytes in the bone marrow at the analyzed dose. However, nanoparticles administration showed a significant effect on the leukocytes counts in animals treated with DMSA coated nanoparticles 24 h after injection. This response is not observed in animals treated with PEG modified nanoparticles which justifies the use of this polymer in biomasking strategies.
Introduction
Magnetic nanoparticles based on iron oxides are being used as contrast agents in magnetic resonance imaging (MRI). Clinical applications of these materials in drug delivery, hyperthermia and diagnosis are also being considered seriously 1 . However, a first requisite for in vivo applications is blood compatibility 2 , otherwise these materials would be immediately discarded for intravenous administration.
Interactions of nanoparticles with blood usually start with protein adsorption 3 , and subsequently derive in coagulation problems and other disturbances. Several studies have reported that environmental nanoparticles significantly increase the risk and worsen the prognosis of cardiovascular diseases due to the induction of thrombotic complications 4 . Protein adsorption is favored by surface charges, especially positive charges, and can be minimized with an appropriate coating. Carbohydrates and other biological polymers have been considered to be effective against protein adsorption, although polyethylene glycol is the preferred coating for these purposes 5, 6 . However there are only few studies investigating the hematological effects of nanoparticles in vivo in spite of the fact that the majority of nanoparticle formulations are intended for systemic administration in clinical applications. In addition, there are no standard methodologies for the in vitro assessment of the blood compatibility of these nanoproducts.
The in vitro biocompatibility studies should also include evidence of hemolysis.
The unique physicochemical properties of the nanoparticles could cause hemolysis by acting on the membrane of red blood cells. Several studies have revealed the effect of the nanoparticles on the blood by measuring their hemolytic action in vitro 7 . However, direct results interpretation of these studies is complicated due to variability of the experimental conditions such as incubation time of blood with the nanoparticles, the wavelength at which the hemoglobin is quantified, the centrifugation forces, blood storage time and conditions and blood source (human or rabbit) 8 .
Platelets are very sensitive to contact with biological substances, such as collagen, ADP and epinephrine, and non-biological ones, including ristocetin, that are commonly used in the hematology laboratory to detect functional defects of platelets. Foreign materials and high shear stress can also induce platelet aggregation. When this occurs they tend to produce micro aggregates that are easily detected by modern blood cell counters because they decrease the number of platelets and alter the size distribution curve. Nanoparticles can potentially damage the cell membrane and even the cytoplasm since they can penetrate inside cells. Blood cell counters not only quantify blood cells but also can detect abnormalities in shape, size and homogeneity.
This study was designed specifically to investigate whether iron oxide magnetite nanoparticles with a narrow size distribution (Mean size=7 nm; SD < 0.15) coated with different polymers (Dimercaptosuccinic acid (DMSA) and Polyethylene glycol (PEG)) could lead to blood coagulation disorders and affect hematological parameters in vitro and in vivo. These bioferrofluids have previously been used in biodistribution and pharmacokinetics studies in different animal models. PEG coated nanoparticles have shown a good performance as MRI long circulating agents due to the effect of incorporation of PEG into the nanoparticle surface which is known to provide stealth coating to camouflage them, and thus, temporarily bypass recognition by macrophages 9 . As with any device or pharmaceutical product, DMSA or PEG coated nanoparticles intended for biomedical application must also be subjected to extensive blood biocompatibility testing before regulatory approval for administration to patients. To our knowledge, the blood biocompatibility of these products has not been established till date.
Previous hematological studies on iron oxide nanoparticles coated with poly(4-vinyl pyridine)-polyethylene glycol (PVP-PEG) brush copolymers indicated a non-specific anticoagulant effect of the bioferrofluid 10 .
We have carried out an extensive in vitro biocompatibility study of our bioferrofluids with blood including coagulation studies, hemolysis and quantification of leukocytes, erythrocytes and platelets, to rule out immediate cytotoxicity of nanoparticles or contact spontaneous platelet aggregation [11] [12] [13] . Moreover, blood toxicity of these nanomaterials has been studied in terms of global tests (Prothrombin time (PT), activated partial thromboplastin time (aPTT), Fibrinogen), thrombus-elastography, platelet aggregation and degradation products of fibrinogen and fibrin. Recently, a detailed description of methods has been published, which focuses on the global plasma coagulation tests (PT, aPTT, Fibrinogen) and platelet aggregation 14 . The doses used in this study are higher than the therapeutically relevant concentration but describe the range where we observed an effect on hematological parameters. The recommended dosage for products like Feridex IV, Berlex Laboratories; and Endorem, Guerbet is 0.56 mg of iron per kg of body weight 15 . It is also in the same range as those used in other cytotoxicity assays published previously 16 .
Some studies have evaluated the compatibility of nanoparticles with the blood coagulation system 17 in vivo in rats 18 and rabbits 19 , while most of the authors have carried out only in vitro tests [10] [11] [12] 20 .
Finally, we have carried out hematotoxicity studies in vivo including a complete blood count analysis and also possible genotoxic effects in the hematopoietic function of the bone marrow. 
Materials and methods

Materials
Magnetic nanoparticles preparation
Magnetite nanoparticles were obtained via thermal decomposition of an iron coordination complex as a precursor to ensure nanoparticle homogeneity in size and shape following the method reported by Sun and co-workers 21, 22 . Particle size and shape were studied using 
Complete blood counts (CBC) studies
Control blood: Blood samples were obtained from healthy human volunteers. Samples were collected in EDTA K3, 1.8 mg/mL vacutainer. The blood samples were processed for CBC studies using a Coulter LH 780 analyzer from Beckman Coulter.
Blood treated with bioferrofluids: the investigated materials were mixed with the blood samples at dilutions 1:10 and 1:100 and processed for blood cell counting.
Hemolysis studies
Blood samples were obtained from healthy human volunteers.
Samples were collected in Lithium heparin 17 UI/mL vacutainer tubes. The samples were processed for the measurement of the free hemoglobin using a double beam spectrophotometer Analytic JenaSpecord 205 with wavelength range between 500-630 nm.
Hematology analysis in vivo
Rats were randomly divided into three groups (n= 4/group), the control and the experimental groups: Animals treated with NP-DMSA and animals treated with NP-PEG-(NH 2 ) 2 . The animals of the experimental groups received a single dose of magnetite nanoparticles (2.5 mg/kg B.W.) through the tail vein. This dose is five times larger than the recommended one for commercial products (~0.5 mg/kg B.W.) 14 but it is well below the doses used in many experimental works (10 mg/kg B.W) 23 . Rats were anesthetized with a mixture of Ketamine/Xylazine and peripheral blood was collected at 24 hours, 7, 15 and 30 days after nanoparticles administration.
Control animals were sacrificed progressively during the study.
Blood collected in EDTA (10 %) was analyzed using a Sysmex pocH-100i™ Automated Hematology Analyzer.
Genotoxicity test
Comet Assay: The extent of DNA damage was determined via alkaline single cell gel electrophoresis according to N.P. Singh and cols. 24 with some modifications. Briefly, 60 µL of peripheral blood was mixed with 240 µL of 0.5% low melting point agarose. The mixture was pipetted into slides (2 slides/rat) precoated with 1.5% normal melting point agarose and covered with a coverglass. Then, the slides were incubated in freshly prepared lysis buffer (NaCl 2.5 M, EDTA 100 mM, Tris 10 mM, 1% Triton x-100, 10% DMSO) in the dark for 2 h at 4°C. The slides were then placed in a horizontal electrophoresis tank containing fresh electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH 13) and incubated for 30 min at 4°C.
Electrophoresis was conducted for 30 min at 25 Volts and 300 mA. In the case of NP-DMSA treated plasma, it was observed that: a) the aPTT measurements for bioferrofluids treated plasma, returned to normal levels, 30.83 ± 0.74 s after mixing with normal plasma (1:1) The prolonged aPTT values are probably due to an inhibition of intrinsic coagulation factors after nanoparticle addition 27 . When nanoparticles are in contact with a biological fluid their surface will be covered with a "corona" of biological macromolecules. Surface charge plays a fundamental role in this process, and this is evidenced by a higher inhibition effect of NP-DMSA compared with PEGcoated nanoparticles.
Fibrinogen measurements by von Clauss method
To avoid the possible interference of the suspended nanoparticles on the fibrinogen derived method, which is based on light dispersion, Spectrophotometric measurements did not show any peak referred to the free hemoglobin at wavelength 580 nm as shown in Figure 5 .
These curves were consistent with their control. These results are in agreement with CBC results presented above.
In vivo studies
The influence of DMSA and PEG coated nanoparticles in hematological parameters was tested in a Wistar rat animal model up to 30 days after administration at a single dose of 2.5 mg/kg B.W.
Complete blood counts are summarized in Figure 6 . It was observed a slightly decrease in erythrocytes counts after 24 h. Nanoparticles administration also showed significant differences with the control in 
Genotoxicity test
Many studies have shown that nanoparticles generate reactive oxygen species, deplete endogenous antioxidants, alter mitochondrial function and produce oxidative damage in DNA 29 .
Single Cell Gel Electrophoresis assay (also known as Comet Assay)
and Micronucleus test were performed in order to analyze possible hematotoxicity and genotoxicity associated to magnetite nanoparticles administration in a Wistar rat animal model 30, 31 .
Electrophoresis at high pH allows detection of single and double strand DNA breaks, alkali-labile sites (expressed as single-strand breaks), single-strand breaks associated with incomplete repair, and DNA-DNA or DNA-protein cross-links 24, 32 . On the other hand Micronucleus test detects irreversible structural damages, for example, chromosomal damages 33 . Total damage (TD %) and micronucleus frequencies showed no significant differences between the animals treated and control groups ( Figure 7A ) concluding that these bioferrofluids do not cause genotoxic effects at the analyzed dose. 
Citotoxicity test
Bone marrow has been used for evaluation of micronucleus frequencies in vivo in rodents in genotoxic risk characterization but also as a citotoxicity test 32, 34, 35 . This tissue has the most active cell division, therefore mutagenic or toxic effects of drugs or other chemicals can cause diseases like aplastic anemia, which manifests as the cessation of normal blood cell production; or leukemias, that produce excessive hematologic cancer cells 36 .
In this study the ratio of polychromatic to normochromatic erythrocytes (PCE, NCE) was scored and the %PCE was determined according to the formula described in the Methods section. Thus, no significant differences were observed between the animals treated and the corresponding control groups ( Figure 7B ), indicating that these bioferrofluids do not affect erythropoiesis or cell proliferation of polychromatic erythrocytes in the bone marrow at the analyzed dose.
Conclusions
Uniform magnetite nanoparticles coated with dimercaptosuccinic acid (DMSA) and polyethylene glycol (PEG) have been used in this work to assess their hematotoxicity, evaluating the blood toxicity in vitro and in vivo in a rat model. The in vivo tests showed that these bioferrofluids do not cause genotoxic effects and do not affect erythropoiesis or increase the number of immature erythrocytes in the bone marrow at the analyzed dose. However, nanoparticles administration showed a significant effect on the leukocytes counts in animals treated with DMSA coated nanoparticles 24 h after injection. This response is not observed in animals treated with PEG modified nanoparticles which justifies the use of this polymer in biomasking strategies.
